Hospital and Neurodevelopmental Outcomes in Nano-Preterm Infants Receiving Invasive vs Noninvasive Ventilation at

Vivek V Shukla1, J Paige Souder2, Grant Imbrock1

  • 1Division of Neonatology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham.

JAMA Network Open
|August 29, 2022
PubMed

Insights

Noninvasive respiratory support for nano-preterm infants is feasible but does not reduce bronchopulmonary dysplasia or death risk compared to early intubation. Invasive support showed a lower incidence of severe intraventricular hemorrhage or death.

Area of Science:

  • Neonatal Medicine
  • Pediatric Respiratory Care
  • Perinatology

Background:

  • Infants born between 22 0/7 and 23 6/7 weeks' gestational age (nano-preterm) face high risks of adverse outcomes.
  • Noninvasive respiratory support benefits infants born at later gestations (24 0/7–27 6/7 weeks), but evidence for nano-preterm infants is limited.

Purpose of the Study:

  • To test if early intubation (≤10 minutes post-birth) increases bronchopulmonary dysplasia (BPD) or death by 36 weeks' postmenstrual age (PMA) in nano-preterm infants.
  • To compare outcomes between noninvasive and invasive respiratory support strategies initiated at birth for this high-risk group.

Main Methods:

  • Observational cohort study of 230 nano-preterm infants (22 0/7–23 6/7 weeks' GA) at a level IV NICU (2014–2021).
  • Infants were grouped by first intubation timing: >10 minutes (noninvasive support) vs. ≤10 minutes (invasive support).
  • Primary outcome: composite of BPD (physiologic definition) or death by 36 weeks' PMA.

Main Results:

  • The incidence of BPD or death by 36 weeks' PMA did not differ significantly between noninvasive (94.3%) and invasive (90.9%) support groups (aOR, 2.09; P=.24).
  • Invasive respiratory support was associated with a lower incidence of severe intraventricular hemorrhage or death by 36 weeks' PMA (aOR, 2.20; P=.03).
  • Nano-preterm infants in the noninvasive group had a median GA of 23.6 weeks, while the invasive group had a median GA of 23.0 weeks.

Conclusions:

  • Noninvasive respiratory support is feasible in the first 10 minutes for nano-preterm infants but does not decrease the risk of BPD or death compared to early intubation.
  • Early intubation and surfactant delivery may be a viable strategy for this extremely preterm population, potentially reducing severe intraventricular hemorrhage.
Abstract